Abstract:We found specific gene sets and cell clusters that were correlated with the prognosis for clear cell renal cell carcinoma (ccRCC). We also discovered transcription factor regulons and ligand–receptor pairs that might become potential therapeutic targets. Single-cell RNA sequencing (scRNA-seq) has yielded insights into tumour origin or immune composition's effect on clinical outcome in ccRCC,1, 2 but was limited to characterize potential new targets. Here, we performed scRNA-seq on seven patients' tumours and matched five normal samples (Table S1 and Figure 1A). A total of 37 243 cells were divided into six cell types according to marker genes (Figure 1B). Potential malignant cells were distinguished via copy number variations (CNVs).3 Epithelial cells having CNVs were named as 'changed' (Figure 1B). The top five differentially expressed genes (DEGs) were shown (Figure 1E). According to the cell distributions and sample origins (Figure 1C), we found the heterogeneity of tumour epithelial cells was more obvious than other cells. We then used the Harmony algorithm to minimize the batch effect (Figure 1D,F). Myeloid cells appeared more in tumours than in normal samples, indicating their active role in tumourigenesis (Figure 1G). Scoring for genes with different biological functions (Table S2) indicated that hypoxia score was highest in tumour and endothelial cells (Figure S1). According to canonical makers (Table S3), epithelial cells were divided into six types (Figure 2A): tumour cell, proximal tubule cell (PT), collecting duct cell (CD), principal cell (PC), podocytes and VCAM1+ PT. The ccRCC was thought to originate from VCAM1+ PT,1 and our data confirmed the existence of this cluster of cells, and these cells were only found in normal samples (Figure S2B). Based on CNVs, epithelial cells were divided into three subpopulations: tumour, normal and 'changed'. Normal cells were mostly PT, while 'changed' cells were comprised CD, PC and VCAM1+ PT (Figure 2B,C and Figure S2A). To reveal the dynamics of transcriptional profiles of epithelial cells, we applied trajectory analysis (Figure 2D,E). Normal cells are located at the right end of the pseudotime trajectory, while tumour cells are located at the left end, indicating a transition tendency. VCAM1+ PT occupied all the branches, suggesting their pluripotency (Figure 2I). PAGA also confirmed VCAM1+ PT were most similar to tumour cells (Figure 2F). Monocle2 defined the branches of tumour cells as two 'states' (state 3 and state 4, Figure 2E). State 3 genes functioned in proliferation, hypoxia and angiogenesis, while state 4 genes functioned in stress and immune response (Figure 2G,H and Figure S2C,D and Table S4). High expression of state 3 genes was related to improved overall survival in a TCGA cohort containing 531 patients4 (Figure 2J). NMF5 found six tumour epithelial-specific gene programs (Figure 2K). Highly expressed program 2 was correlated with favourable overall survival, while highly expressed program 4 (Table S5) was correlated with unfavourable survival (Figure 2L,M). Program 2 functioned in interferon signalling and antigen processing (Figure 2N), whereas program 4 functioned in stress response, growth and apoptosis (Figure 2O). SCENIC6 discovered transcription factor regulons differentially expressed in epithelial cells (Figure 3A,B). NR1I3 regulon was normal cell specific, while IRX3 regulon was located mainly in tumour cells (Figure 3C). Co-expressed regulons clustered together by correlation analysis (Figure S3A). IRX3 level in the tumour was apparently higher than normal samples (Figure 3D). IRX3 was correlated to ccRCC marker CA9 and EMT gene VIM (Figure 3E and Figure S3B). High expression of IRX3 was correlated to unfavourable survival in the TCGA cohort (Figure S3C). We also performed immunofluorescence staining for the seven patients and tissue microarrays containing 340 ccRCC samples. We found IRX3 staining in patient 1t (Figure 3F) and tissue microarrays (Figure 3G), and the positive proportions increased with tumour grade progression (I: 13%, II: 9%, III: 53%). IRX3 had two locations: cytoplasm and nuclei (Figure 3F,G). The patient 1t was diagnosed with lung metastasis after nephrectomy. The metastatic sites had nuclei-localized IRX3, whereas the primary sites had cytoplasm-localized IRX3 (Figure 3F). ccRCC cell lines A498 and 769-P had cytoplasm localization, whereas OSRC-2, 786-O and Caki-1 had nuclei localization (Figure S3D). Location change suggested function change, which needs more investigations. Knockdown of IRX3 significantly decreased the viability, wound healing, migration and invasion ability of OSRC-2 cells (Figure 3H,I and Figure S3E). IRX3 played a role in ccRCC progression. Myeloid cells had 10 clusters (Figure 4A and Figure S4A). We generated a gene signature file of the 10 clusters and used CIBERSORTx7 to infer cell-type proportions in the TCGA cohort. Higher infiltration of C4_C3AR1+ macrophages in the tumour was associated with worse survival, while higher infiltration of C3_CD163+ macrophages or C8_cDC2 was related to improved survival (Figure 4B). C4_C3AR1+ cells expressed tissue-resident marker CD74 and CD81 and scavenger receptor MSR1, which was an anti-inflammatory M2 marker. M1 and M2 gene signatures (Table S6) scoring found that C1_IL1B+ cells had higher M1 score, while C3_CD163+, C5_MSR1+ cells had higher M2 scores (Figure 4D). RNA velocity analysis8 indicated M1 to M2 transition tendency exist (Figure 4C), and M2-like cells were mainly from tumour samples based on the sample origins (Figure S4B). In subgroups of T cells (Figure 4E), CD8+ T cells had three clusters: 4-1BB+, ex_ef (expressing exhausted makers and effector molecules) and cycling T cells. Higher infiltration of 4-1BB+ T cells or NKT0 cells was related to worse survival, while higher infiltration of ex_ef T cells was related to better survival (Figure 4F). The previous opinion that CD8+ T cells predicted bad outcomes9 was not accurate, more markers were needed to evaluate the prognosis. CellPhoneDB inferred interactions between different cells. The strongest interactions appeared between epithelial and myeloid cells (Figure S4C,D and Table S7). Typical crosstalks were listed (Figure 4G,I). Intriguingly, C3_C3AR1 crosstalk happened between tumour epithelial and myeloid cells. The exact roles of complement components C3 and C3AR1 in ccRCC have not been described. C3 and C3AR1 did co-localize in tumour samples (Figure 4H). LGALS9_CD47 interactions were also obvious (Figure 4I), staining validated this crosstalk (Figure 4J). CD99_PILRA between endothelial and myeloid cells (Figure 4I) suggested a decreasing immune infiltration effect.10 LGALS9_HAVCR2/TIM3 also reminded a suppressive impact, suggesting endothelial cells' immune-suppression role. Our studies revealed gene sets and specific macrophage and T cell clusters that can predict prognosis. Potential therapeutic targets such as IRX3 and inhibitory interactions among different cells provided insights for ccRCC therapies. The study was supported by Ministry of Science and Technology of the People's Republic of China (2017YFA0102900), National Natural Science Foundation of China (81630073 and 81872406 to Wei-Qiang Gao, 82002689 to Man Zhang), China Postdoctoral Science Foundation (2019M651484 to Man Zhang), the Science and Technology Commission of Shanghai Municipality (20JC1417600, 21JC1404100 to Wei-Qiang Gao), Peak Disciplines (Type VI) of Institutes of Higher Learning in Shanghai, the Shanghai Jiao Tong University STAR and Scientific and Technological Innovation Funds and the KC Wong foundation to Wei-Qiang Gao. The authors declare no conflict of interest. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Establishment of Intratumor Bacteria As Biomarkers in Renal Clear Cell Carcinoma

PD49-08 CORRELATING IMMUNE CELL INFILTRATION PATTERNS WITH RECURRENT SOMATIC MUTATIONS IN CLEAR CELL RENAL CELL CARCINOMA

Intratumoral CXCL13+CD8+T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma

Correlating Immune Cell Infiltration Patterns with Recurrent Somatic Mutations in Advanced Clear Cell Renal Cell Carcinoma

MP39-20 CLINICOPATHOLOGICAL AND PROGNOSTIC IMPACT OF SOMATIC MUTATIONS IN CHINESE PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA

Comprehensive Genomic Profiling in Chinese Patients with Clear Cell Renal Cell Carcinoma.

PD04-07 HIGHER PD-L1 MRNA LEVEL IN CLEAR CELL RENAL CELL CARCINOMAS IS ASSOCIATED WITH A FAVORABLE OUTCOME

MP10-05 MULTIGENE ASSAYS TO PREDICT MALIGNANCY AND DRUG EFFICACY IN RENAL CELL CARCINOMA AND PAN-CANCER: DEVELOPMENT AND DUAL EXTERNAL VALIDATION

INTRA-TUMOR MOLECULAR HETEROGENEITY OF CLEAR CELL RENAL CELL CARCINOMA SEEMS TO CONTRIBUTE TO THE DIVERSITY OF RESPONSE TO TARGETED THERAPIES

Kidney Cancer: Epidemiology & Evaluation/Staging IIMP78-09 IDENTIFICATION AND VALIDATION OF AN 8-GENE EXPRESSION SIGNATURE FOR PREDICTING HIGH FUHRMAN GRADE RENAL CELL CARCINOMA

1070 INTEGRATED ANALYSIS OF DIFFERENTIAL EXPRESSED SERUM PROTEINS IN T1 STAGE RENAL CELL CARCINOMA BY ITRAQ TECHNOLOGY

Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma

Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis

MP10-01 CD73 BLOCKADE POTENTIATES FH-CGAS-STING AXIS IN THE MICROENVIRONMENT OF RENAL CELL CARCINOMA

MP01-12 DETECTION OF UROTHELIAL CARCINOMA BASED ON COPY NUMBER PROFILES OF URINARY CFDNA USING SHALLOW WHOLE-GENOME SEQUENCING

Abstract 3873: Profiling the Tumor Microenvironment Within Clear Cell Renal Cell Carcinoma by Single-Nuclei RNA-Seq

Integrative Bioinformatics Analysis Demonstrates the Prognostic Value of Chromatin Accessibility Biomarkers in Clear Cell Renal Cell Carcinoma

The intrarenal landscape of T cell receptor repertoire in clear cell renal cell cancer

Identification and validation of dichotomous immune subtypes based on intratumoral immune cells infiltration in clear cell renal cell carcinoma patients

Single Cell Analysis Reveals Intra‐tumour Heterogeneity, Microenvironment and Potential Diagnosis Markers for Clear Cell Renal Cell Carcinoma

MP15-11 CD103 + CD8 + TISSUE-RESIDENT MEMORY T CELLS INFILTRATION PREDICTS CLINICAL OUTCOME AND ADJUVANT THERAPEUTIC BENEFIT IN MUSCLE-INVASIVE BLADDER CANCER